Expert Consensus
International Consensus on Severe Lung Cancer—The Second Edition
Original Article
Deep learning model based on automated CT image segmentation for predicting the optimal radiotherapy protocol in limited-stage small cell lung cancer patients: a multicenter study
Association of PD-L1 expression and clinical outcomes in ROS1-rearranged advanced non-small cell lung cancer treated with entrectinib
DNA hypomethylation-activated PRAME drives early-stage lung adenocarcinoma recurrence via ZNF740 and PI3K/AKT/mTOR signaling
Predictors of radiation pneumonitis after postoperative radiotherapy in completely resected pathologic stage III-N2 non-small cell lung cancer: a secondary analysis of a prospective cohort
Perioperative anxiety and depression predict long-term survival after neoadjuvant therapy in non-small cell lung cancer: a multicenter analysis
TLR7 induces autophagy in non-small cell lung cancer tumor cells and influences anti-tumors responses in patients
Prognostic nomogram for extensive-stage small-cell lung cancer in the immunotherapy era: a multicenter study of first-line platinum-etoposide with or without a PD-1/PD-L1 inhibitor
LUADnet: a deep learning model for prediction of clinical outcomes in lung adenocarcinoma based on gene expression signatures
Perioperative inflammation, anesthesia modulation and cellular signaling in lung cancer: an integrated transcriptomic and single-cell analysis
Mid-term efficacy and safety of transbronchial cryoablation for stage IA peripheral lung cancer: a retrospective analysis
Preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)-based strategy for predicting negative mediastinal lymph node metastasis status in non-small cell lung cancer
Distinct mutation landscape with similar immune microenvironment in primary simultaneous operable squamous cell carcinoma and peripheral-type small-cell lung cancer
Impact of effective dose to immune cells (EDIC) on survival in limited-stage small cell lung cancer treated with radiotherapy and immunotherapy
Air pollution, driver mutations, and survival in non-small cell lung cancer: insights from a high-altitude Hispanic cohort
TROP2 expression as a prognostic predictor for osimertinib in patients with EGFR-mutant non-small cell lung cancer
Occupational physical workload and risk of lung cancer and chronic respiratory diseases: a prospective cohort study of the UK Biobank
Accelerating tumor evolution and enhancing immunotherapy efficacy in lung adenocarcinoma based on EXO1 inhibition
“Variant matters”: the impact of ALK fusion subtypes on progression and response in non-small-cell lung cancer—data from clinical practice from Polish centers
Association between patient-reported outcomes and pathological response in neoadjuvant chemoimmunotherapy—a post hoc analysis of the TD-FOREKNOW trial
Evaluating the early therapeutic response of radiofrequency ablation in rabbit VX2 lung tumors: a comparison of four diffusion weighted imaging models
Novel lipid metabolism-related gene signature associated with clinical and immune features in lung adenocarcinoma patients experiencing lymph node metastasis
Assessing current diagnostic, staging, and treatment practices in community and academic centers for individuals with stage IB–IIIA non-small cell lung cancer
The IASLC grading system as a predictor for EGFR-TKI therapy in patients with EGFR-mutant lung adenocarcinoma
Beyond miRNAs: exploratory profiling of PIWI-interacting RNAs and small nucleolar RNAs in non-small cell lung cancer-related malignant pleural effusions
Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in KRASG12C-mutant non-small cell lung cancer and exploratory HER2 profiling in human tumors
Timing of definitive pleural intervention within systemic anticancer therapy in malignant pleural effusion from high-response lung cancers: a retrospective single-center cohort study
Consolidative thoracic radiotherapy after first-line chemoimmunotherapy in extensive-stage small-cell lung cancer: a multicenter retrospective study
Real-world effectiveness and safety of adebrelimab as first-line treatment in patients with extensive-stage small cell lung cancer
Identification of prognostic biomarkers and immunotherapy response predictors in lung adenocarcinoma: integrative Mendelian randomization and machine learning analysis
Cadonilimab induction and consolidation for unresectable stage III non-small cell lung cancer patients receiving concurrent chemoradiation: safety run-in results of a prospective, phase II trial
Gender disparities in the overall survival of patients with minimally invasive squamous cell carcinoma of the lung: a retrospective analysis of the Surveillance, Epidemiology, and End Results Program database
Review Article
The resistance landscape of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer: molecular mechanisms and novel therapeutic strategies
Understanding the dual role of granulocyte-macrophage colony-stimulating factor in the lung cancer tumor microenvironment and its therapeutic implications
From biology to the clinic: research evidence and therapeutic advances of TROP2-targeted antibody-drug conjugates in small cell lung cancer
Pulmonary ground glass opacity tumor: a curable subtype of lung cancer when treated within the “surgical curative time window”
Methylated circulating tumor DNA: technical challenges and clinical applications in non-small cell lung cancer patients—a narrative review
Targeted therapy for stage IA non-small cell lung cancer with EGFR mutations: a scoping review
Lung cancer associated with cystic airspaces in the perioperative immunotherapy era: radiologic and pathologic pitfalls, surgical extent, and management implications
Narrative review of the similarities and differences between immune checkpoint inhibitor- and antibody-drug conjugate-associated pneumonitis
Case Report
A lung squamous cell carcinoma demonstrating spontaneous partial regression of the primary tumor with lymph node metastasis: a case report with analysis of the tumor immune microenvironment
Prolonged complete metabolic response to chemotherapy combined with amivantamab with high grade cutaneous toxicity after osimertinib resistance in an uncommon T751_I759delinsAsp EGFR-mutant lung adenocarcinoma: a case report
Clonal relationship in a rare pulmonary mixed tumor: shared ALK fusion in atypical carcinoid and adenocarcinoma—a case report
Two-year treatment-free sustained remission after chemo-immunotherapy in a 52-year-old male with recurrent ARID1A-mutant lung adenocarcinoma: a case report
ALK-tyrosine kinase inhibitor resistance due to acquired MET amplification in ALK-fusion positive advanced NSCLC effectively treated by lorlatinib-vebreltinib combination: a case report and literature review
Editorial Commentary
Precision medicine in the first-line treatment of EGFR-mutated non-small cell lung cancer: moving beyond “one-size-fits-all”
Survival, toxicity, and sequencing: navigating the new first-line standard established by FLAURA2
Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?
Published online: 22 October 2013Ground glass nodules with 5 years’ stability can grow after 10-year follow-up: do genetic features determine the fate?
Published online: 31 December 2019Non-small cell lung cancer: current treatment and future advances
Published online: 30 June 2016Irreversible EGFR-TKIs: dreaming perfection
Published online: 14 January 2013Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology
Published online: 28 February 2017Recurrence after surgery in patients with NSCLC
Published online: 28 August 2014Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
Published online: 30 June 2019Targeted therapy for non-small cell lung cancer: current standards and the promise of the future
Published online: 24 February 2015Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights
Published online: 28 August 2018Lung cancer prediction using machine learning and advanced imaging techniques
Published online: 14 June 2018The past, present and future of immunotherapy against tumor
Published online: 24 June 2015The epidemiology of lung cancer
Published online: 14 June 2018Lung cancer screening: nodule identification and characterization
Published online: 14 June 2018Biology of invasive mucinous adenocarcinoma of the lung
Published online: 11 October 2017Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey
Published online: 30 June 2019KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach
Published online: 03 April 2013Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)
Published online: 28 August 2021Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Published online: 19 April 2015Global trends of lung cancer mortality and smoking prevalence
Published online: 20 August 2015Angiogenesis in cancer: anti-VEGF escape mechanisms
Published online: 18 February 2012Original Article
Review Article
Editorial
Systematic Review and Meta-analysis
China Lung Cancer Research Highlight
Review Articles
Ceritinib
Onartuzumab plus erlotinib
Nivolumab
Brief Report
Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer
Below are the latest Translational Lung Cancer Research articles published online ahead of print publication.











